School of Nursing Benemérita Universidad Autonoma de Puebla
Puebla City, Puebla, 72304, Mexico
NCT Number: NCT06920589
Intervention aimed at increasing knowledge of the human papillomavirus in homosexual men as a means of preventing sexually transmitted diseases and controlling complications associated with the pathology.
Looking for future studies?
Notify MeMale
Interventional
Not applicable
Puebla City, Puebla, 72304, Mexico
Introduction: The World Health Organization reports a 21% prevalence of Human Papillomavirus (HPV) in men, with rates reaching 93% among homosexual men. This group exhibits specific characteristics, such as high rates of sexually transmitted infections (STIs) due to multiple partners and inconsistent condom use, along with limited knowledge about HPV. The intervention "Safe and Protected Sex", using a horizontal methodology, aims to address this health issue.
Objective: To evaluate the effect of the "Safe and Protected Sex" program on HPV knowledge among homosexual men.
Methodology: A quasi-experimental study with a test-retest design and convenience sampling. The sample size was calculated using n'Query Advisor 4.0, resulting in 20 homosexual men per group (n=40).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study used the "Safe and Protected Sex" intervention (Báez et al., 2019), adapted and validated from an HIV prevention program to focus on HPV. The intervention consists of a single module with two stages aimed at increasing HPV knowledge by enhancing personal (self-determination) and social (controlled behavior) motivation.
Module 1: "Nursing Consultation on HPV" This structured, planned process follows Corona and Kaltmeier's (2012) horizontal methodology, promoting self-care through social support and trust in nurse-patient dialogue. The goal is to provide counseling on HPV prevention and responsible sexual behavior while acknowledging participants' prior knowledge.
Stage 1: A 4.21-minute educational video, "HPV Fun Facts," uses persuasive narrative to explain HPV transmission, symptoms, complications, and prevention.
Stage 2: A 45-minute "Friendly Educational Guidance" session uses open-ended questions to explore participants' experiences.
a brochure is provided with general information about the human papilloma virus in men, including the form of contagion, diagnosis, treatment and the use of condoms for prevention.
Time frame: 1 month
This Spanish-language questionnaire is intended to measure knowledge about HPV. It is structured by 38 questions, distributed in four dimensions: 1) causal agent of HPV (1, 2 and 3); 2) risk factors (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 and 15); 3) signs and symptoms (16, 17, 18, 19 and 20) and 4) prevention, diagnosis and treatment (21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 and 38).
The structure for answering each of the questions is through a Likert-type scale, where three possible options are presented: A= true, B= false and C= don't know. To obtain the cut-off points of the instrument, percentiles (zero to 100) will be used, where Percentile 1 (P125) = no knowledge, Percentile 2 (P250) = insufficient knowledge, Percentile 3 (P375) = fair knowledge and Percentile 4 (P4100) = adequate knowledge
Time frame: 1 month
To measure personal motivation (self-determination), the Personal Motivation Questionnaire adapted to the Mexican context. It consists of 13 items, which address the preventive behaviors performed by the homosexual male as a result of an emotional-cognitive process, derived from the values and beliefs related to knowledge of HPV, which are manifested during the nursing consultation, through the intervention "Safe and Protected Sex". The response form is Likert type: 1= Strongly agree, 2=Significantly agree, 3= Agree, 4= Neither agree nor disagree, 5= Disagree, 6= Strongly disagree, 7= Strongly disagree, also the score ranges from 13 to 91 points, however for a better interpretation of the data the values are converted into a scale from 0 to 100, where high scores indicate a higher personal motivation during the nursing consultation.
The validity of the instrument was through eight experts, which yielded a content validity index
Time frame: 1 month
To measure social motivation (controlled behavior), the Social Motivation Questionnaire adapted to the Mexican context . It consists of 15 items, which deal with the actions that the homosexual male has derived from the social support perceived during the nursing consultancy with horizontal methodology, granted through the intervention "Safe and Protected Sex" directed towards HPV. The response form is Likert type: 1= Strongly agree, 2= Strongly agree, 3= Agree, 4= Neither agree nor disagree, 5= Disagree, 6= Strongly disagree, 7= Strongly disagree, also the score ranges from 15 to 105 points, however for a better interpretation of the data the values are converted into a scale from 0 to 100, where high scores indicate a higher extrinsic motivation during the nursing consultation.
Hospital Univeristario Benemerita Universidad Autonoma de Puebla
Other
Intervention Toward Knowledge of Human Papillomavirus in Homosexual Males
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07329907
DNA Virus Infections, Human Papilloma Virus (HPV)
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT07307131
Cutaneous Warts, Human Papilloma Virus (HPV)
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT07110909
Human Papilloma Virus (HPV)
Tokat Province, Center, Turkey (Türkiye)
View Trial DetailsNCT06909370
Human Papilloma Virus (HPV)
Istanbul, Türkiye, Turkey (Türkiye)
View Trial Details